2017 Compounding Prescription Filling 
pharmaphorum
FEBRUARY 18, 2021
Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively. In late 2017, the FDA approved Admelog, Sanofi’s biosimilar of Humalog. Since losing exclusive rights in 2017, Pfizer undertook an over-the-counter switching strategy to guard against revenue loss.
The Checkup by Singlecare
APRIL 22, 2025
Ozempic was approved by the Food and Drug Administration (FDA) in 2017 for the treatment of Type 2 diabetes. How many people use compounded semaglutide? The number of people taking compounded semaglutide is difficult to accurately report because compounding pharmacies and facilities that make it arent required to report their sales.
Expert insights. Personalized for you.
52 
Let's personalize your content